Literature DB >> 7016219

Mini-plasminogen: a mechanism for leukocyte modulation of plasminogen activation by urokinase.

L A Moroz.   

Abstract

Urokinase activation of blood fibrinolysis involves polymorphonuclear leukocytes. To determine if a leukocyte proteinase can modulate plasminogen activation, plasminogen was digested with leukocyte elastase. A major product was a small, approximately 34,000 dalton fragment (mini-plasminogen), without lysine-binding function, but with fibrin-binding activity. After urokinase activation, the resulting mini-plasmin had amidolytic activity for a tripeptide plasmin substrate and fibrinolytic activity. By 125I-fibrin assay, activities of mini-plasmin and plasmin (12 nmole/liter) were 38 and 20 ng fibrin lysed/min, respectively. Lysis times of fibrin clots containing urokinase, and mini-plasminogen or plasminogen (800 nmole/liter), were 282 and 290 sec, respectively. Mini-plasmin and plasmin were inhibited similarly by epsilon-aminocaproic acid and normal plasma, but differed in responses to gel filtration fractions of plasma containing alpha 2-antiplasmin and alpha 2-macroglobulin, the primary and secondary plasmin inhibitors. With purified inhibitors, mini-plasmin required higher concentrations of, or longer preincubation with, alpha 2-antiplasmin, and lower concentrations of, or shorter preincubation with, alpha 2-macroglobulin, to produce inhibition equivalent to that observed with plasmin. Leukocyte elastase digests plasminogen to generate a mini-plasminogen which, when activated by urokinase, has a novel pattern of response to the major plasmin inhibitors in plasma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016219

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  The evolution of recombinant thrombolytics: Current status and future directions.

Authors:  Yogender Pal Khasa
Journal:  Bioengineered       Date:  2016-10-03       Impact factor: 3.269

2.  Alpha 2-macroglobulin is the primary inhibitor of miniplasmin in vitro and in vivo in the mouse. Comparison with alpha 2-antiplasmin in simultaneous reaction experiments.

Authors:  S L Gonias; N L Figler
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

3.  Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway.

Authors:  E F Plow
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

Review 4.  Fibrinolytic Enzymes for Thrombolytic Therapy.

Authors:  Swaroop S Kumar; Abdulhameed Sabu
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

5.  A fast-acting elastase inhibitor in human monocytes.

Authors:  E Remold-O'Donnell
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

6.  Secretion of a proteolytic anticoagulant by Ancylostoma hookworms.

Authors:  P J Hotez; A Cerami
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

7.  Inactivation of human tumor cell pro-urokinase by granulocyte elastase.

Authors:  N Kanayama; T Terao
Journal:  Jpn J Cancer Res       Date:  1990-10

8.  A novel serine protease secreted by medicinal maggots enhances plasminogen activator-induced fibrinolysis.

Authors:  Mariena J A van der Plas; Anders S Andersen; Sheresma Nazir; Nico H van Tilburg; Peter R Oestergaard; Karen A Krogfelt; Jaap T van Dissel; Paul J Hensbergen; Rogier M Bertina; Peter H Nibbering
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.